Article Details
Retrieved on: 2025-09-28 22:10:28
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Beck concluded that subcutaneous pembrolizumab broadens delivery options, preserves its clinical profile, and supports patient-centered care.
Article found on: www.onclive.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here